Javascript must be enabled to continue!
Abstract P33: Tumor transcriptome deconvolution identifies genes associated with metastatic progression in colorectal cancer
View through CrossRef
Abstract
Most late-stage colorectal cancer (CRC) patients experience lethal metastasis, often to the liver. However, the molecular mechanisms that drive metastatic progression and adaptation to new tissue environments remain challenging to study in patients. To investigate molecular changes associated with CRC liver metastasis, we analyzed genomic and transcriptomic profiles in a discovery cohort of 49 patients with paired primary and metastatic colorectal cancer samples, along with an independent single-cell RNA sequencing (scRNA-seq) dataset from 16 patients with matched primary and liver metastasis samples. We found that noise arising from tissue-specific gene expression signatures obscured conventional bulk-tumor analytical approaches to profile transcriptomic alterations associated with metastatic progression. To address this challenge, we employed a tumor transcriptome deconvolution approach to specifically profile transcriptomic differences between primary and metastatic cancer cells, localized in the colon and liver tissue environments, respectively. We integrated these results with the scRNA-seq cohort to identify high-confidence transcriptomic alterations associated with cancer-cell metastatic progression in CRC. Intriguingly, metastatic cancer cells showed significant upregulation of genes linked to embryonic development. Surprisingly, our analysis also revealed marked downregulation of cell cycle checkpoint pathways, suggesting impaired cell cycle regulation and proliferation in metastatic lesions, which may limit the efficacy of cytotoxic chemotherapy. Overall, our study demonstrates the importance of tumor transcriptome deconvolution when analyzing and interpreting tumor gene expression data from metastatic lesions. Our results highlight specific molecular alterations in metastatic colorectal cancer cells, which could serve as novel biomarkers or therapeutic targets to detect and prevent lethal disease spread.
Citation Format:
Sinem Kadioglu, Yu Amanda Guo, Simone Rizzetto, Iain Bee Huat Tan, Ker Kan Tan, Anders Jacobsen Skanderup. Tumor transcriptome deconvolution identifies genes associated with metastatic progression in colorectal cancer [abstract]. In: Proceedings of Frontiers in Cancer Science 2025; 2025 Nov 5-7; Singapore. Philadelphia (PA): AACR; Cancer Res 2026;86(13_Suppl):Abstract nr P33.
American Association for Cancer Research (AACR)
Title: Abstract P33: Tumor transcriptome deconvolution identifies genes associated with metastatic progression in colorectal cancer
Description:
Abstract
Most late-stage colorectal cancer (CRC) patients experience lethal metastasis, often to the liver.
However, the molecular mechanisms that drive metastatic progression and adaptation to new tissue environments remain challenging to study in patients.
To investigate molecular changes associated with CRC liver metastasis, we analyzed genomic and transcriptomic profiles in a discovery cohort of 49 patients with paired primary and metastatic colorectal cancer samples, along with an independent single-cell RNA sequencing (scRNA-seq) dataset from 16 patients with matched primary and liver metastasis samples.
We found that noise arising from tissue-specific gene expression signatures obscured conventional bulk-tumor analytical approaches to profile transcriptomic alterations associated with metastatic progression.
To address this challenge, we employed a tumor transcriptome deconvolution approach to specifically profile transcriptomic differences between primary and metastatic cancer cells, localized in the colon and liver tissue environments, respectively.
We integrated these results with the scRNA-seq cohort to identify high-confidence transcriptomic alterations associated with cancer-cell metastatic progression in CRC.
Intriguingly, metastatic cancer cells showed significant upregulation of genes linked to embryonic development.
Surprisingly, our analysis also revealed marked downregulation of cell cycle checkpoint pathways, suggesting impaired cell cycle regulation and proliferation in metastatic lesions, which may limit the efficacy of cytotoxic chemotherapy.
Overall, our study demonstrates the importance of tumor transcriptome deconvolution when analyzing and interpreting tumor gene expression data from metastatic lesions.
Our results highlight specific molecular alterations in metastatic colorectal cancer cells, which could serve as novel biomarkers or therapeutic targets to detect and prevent lethal disease spread.
Citation Format:
Sinem Kadioglu, Yu Amanda Guo, Simone Rizzetto, Iain Bee Huat Tan, Ker Kan Tan, Anders Jacobsen Skanderup.
Tumor transcriptome deconvolution identifies genes associated with metastatic progression in colorectal cancer [abstract].
In: Proceedings of Frontiers in Cancer Science 2025; 2025 Nov 5-7; Singapore.
Philadelphia (PA): AACR; Cancer Res 2026;86(13_Suppl):Abstract nr P33.
Related Results
Globular C1q receptor (p33) binds and stabilizes pro-inflammatory MCP-1: a novel mechanism for regulation of MCP-1 production and function
Globular C1q receptor (p33) binds and stabilizes pro-inflammatory MCP-1: a novel mechanism for regulation of MCP-1 production and function
The protein gC1qR (globular C1q receptor), also named p33, was originally identified as a binding partner of the globular heads of C1q in the complement system. gC1qR/p33 is abunda...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Metastatic colorectal cancer from an epidemiological and immunological perspective
Metastatic colorectal cancer from an epidemiological and immunological perspective
<p dir="ltr">Colorectal cancer (CRC) is the third most common type of cancer and around 8000 persons in Sweden get the diagnosis each year. One in five will have metastases a...
Metastatic colorectal cancer from an epidemiological and immunological perspective
Metastatic colorectal cancer from an epidemiological and immunological perspective
<p dir="ltr">Colorectal cancer (CRC) is the third most common type of cancer and around 8000 persons in Sweden get the diagnosis each year. One in five will have metastases a...
Metastatic colorectal cancer from an epidemiological and immunological perspective
Metastatic colorectal cancer from an epidemiological and immunological perspective
<p dir="ltr">Colorectal cancer (CRC) is the third most common type of cancer and around 8000 persons in Sweden get the diagnosis each year. One in five will have metastases a...
YAP1 and downstream gene alterations in metastatic breast cancer.
YAP1 and downstream gene alterations in metastatic breast cancer.
e13121
Background:
Metastatic breast cancer remains a major clinical challenge, characterized by poor prognosis and limited therapeuti...
Abstract A13: Applied the proteomics characteristics to detect the inherited colorectal adenomas
Abstract A13: Applied the proteomics characteristics to detect the inherited colorectal adenomas
Abstract
Introduction: Current study found that about one-third of the incidence of colorectal cancer have genetic related. Hereditary nonpolyposis colorectal cancer...

